A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis

NCT01857479 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Allergic Bronchopulmonary Aspergillosis

Interventions

DRUG: Inhaled budesonide
DRUG: Inhaled amphotericin

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh